Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 3
1994 2
1995 1
1996 2
1997 3
1998 1
1999 2
2000 1
2001 2
2002 3
2003 2
2005 2
2006 3
2007 3
2009 2
2010 3
2011 4
2012 1
2013 3
2014 7
2015 6
2016 6
2017 11
2018 7
2019 2
2020 2
2021 6
2022 6
2023 3
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Datakvalitet i Norsk hjerteinfarktregister.
Kiel IA, Govatsmark RES, Berge VB, Halle KK, Lydersen S, Risøe C, Haug B, Jortveit J, Malm S, Svingen GFT, Wiksnes M, Berg-Hansen CE, Nilsen LH, Moe EE, Bønaa KH. Kiel IA, et al. Among authors: berge vb. Tidsskr Nor Laegeforen. 2024 Oct 22;144(14). doi: 10.4045/tidsskr.23.0821. Print 2024 Nov 26. Tidsskr Nor Laegeforen. 2024. PMID: 39605159 Free article. Norwegian.
Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis.
Kaschta D, Post C, Gaass F, Al-Tawil M, Arriens V, Balachandran S, Bäumer T, Berge V, Birgel F, Dalski A, Dittmar M, Franke A, Franzenburg S, Fuß J, Gehring B, Gembicki R, Greiten B, Grohte K, Hanker B, Händler K, Harder L, Hellenbroich Y, Herget T, Herrmann G, Hiort O, Hoff K, Hoffmann B, Hornig N, Hüning I, Kautza-Lucht M, Köhler J, Liegmann AS, Lisfeld J, Löscher BS, Margraf NG, Meyenborg M, Möllring A, Muhle H, Penas EMM, Nommels H, Papingi D, Poggenburg I, Pozojevic J, Rosenstiel P, Recke A, Roberts K, Rösler L, Rust F, Salewski MB, Schau-Römer K, Schlein C, Sreenivasan VKA, Toutouna L, Utermann-Thüsing C, van der Ven AT, Volk AE, Wehnert J, Wilson S, Woitschach R, Yumiceba V, Zühlke C, Münchau A, Brüggemann N, Vater I, Caliebe A, Nagel I, Spielmann M. Kaschta D, et al. Among authors: berge v. Genome Med. 2025 Sep 18;17(1):100. doi: 10.1186/s13073-025-01516-7. Genome Med. 2025. PMID: 40963120 Free PMC article.
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment.
de Vos II, Marenghi C, Badenchini F, Boevé ER, Lozano-Uruñuela F, Graefen M, Rannikko AS, Staerman F, Sugimoto M, Kato T, Somford DM, Frydenberg M, Bangma CH, Remmers S, Roobol MJ; Prostate Cancer Research International: Active Surveillance (PRIAS) consortium. de Vos II, et al. BJU Int. 2025 Aug;136(2):245-253. doi: 10.1111/bju.16727. Epub 2025 Apr 14. BJU Int. 2025. PMID: 40223578 Free PMC article.
Can we deliver randomized trials of focal therapy in prostate cancer?
Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M; Prostate Cancer RCT Consensus Group. Ahmed HU, et al. Among authors: berge v. Nat Rev Clin Oncol. 2014 Aug;11(8):482-91. doi: 10.1038/nrclinonc.2014.44. Epub 2014 Apr 22. Nat Rev Clin Oncol. 2014. PMID: 24751803 Review.
Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.
Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU. Donaldson IA, et al. Among authors: berge v. Eur Urol. 2015 Apr;67(4):771-7. doi: 10.1016/j.eururo.2014.09.018. Epub 2014 Oct 1. Eur Urol. 2015. PMID: 25281389 Free PMC article.
[The PSA test must be used more astutely].
Berge V, Beisland C. Berge V, et al. Tidsskr Nor Laegeforen. 2023 Sep 4;143(12). doi: 10.4045/tidsskr.23.0528. Print 2023 Sep 5. Tidsskr Nor Laegeforen. 2023. PMID: 37668129 Free article. Norwegian. No abstract available.
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.
Ouellet V, Erickson A; GAP1 UTMAs Contributing Investigators; Wiley K, Morrissey C, Berge V, Moreno CS, Tasken KA, Trudel D, True LD, Lewis MS, Svindland A, Ertunc O, Vidal ID, Osunkoya AO, Jones T, Bova GS, Lamminen T, Achtman AH, Buzza M, Kouspou MM, Bigler SA, Zhou X, Freedland SJ, Mes-Masson AM, Garraway IP, Trock BJ, Taimen P, Saad F, Mirtti T, Knudsen BS, De Marzo AM. Ouellet V, et al. Among authors: berge v. Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):715-727. doi: 10.1158/1055-9965.EPI-21-0600. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35131885 Free PMC article.
Health-related quality of life after myocardial infarction.
Govatsmark RES, Halle KK, Garratt AM, Bønaa KH, Berge VB, Hanssen TA. Govatsmark RES, et al. Among authors: berge vb. Tidsskr Nor Laegeforen. 2025 Mar 20;145(5). doi: 10.4045/tidsskr.24.0179. Print 2025 Apr 22. Tidsskr Nor Laegeforen. 2025. PMID: 40272144 Free article. English, Norwegian.
101 results